Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

13.50

+0.17 (1.28%)

At close: Jun 8, 2026, 4:00 PM EDT

13.24

-0.26 (-1.93%)

After-hours: Jun 8, 2026, 7:15 PM EDT

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,917	1,606	386	92	116	22
Market Cap Growth	212.41%	316.55%	321.47%	-20.91%	418.86%	-50.32%
Enterprise Value	1,746	1,419	278.77	9.56	-2.67	-5.86
Last Close Price	13.50	12.52	4.12	1.34	1.93	0.78
PB Ratio	10.07	8.77	3.87	1.11	1.08	1.31
P/TBV Ratio	11.11	9.21	4.22	1.61	1.16	1.05
EV/EBITDA Ratio	-	-	-	-	0.09	0.18
EV/EBIT Ratio	-	-	-	-	0.09	0.18
EV/FCF Ratio	-	-	-	-	0.09	0.20
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.02	0.51
Net Debt / Equity Ratio	-0.99	-1.02	-1.07	-0.99	-1.04	-1.30
Net Debt / EBITDA Ratio	3.25	3.81	2.08	2.42	3.73	0.69
Net Debt / FCF Ratio	3.77	4.45	2.78	2.56	3.93	0.77
Quick Ratio	24.14	19.31	10.24	14.25	8.99	2.89
Current Ratio	24.75	19.66	10.41	15.03	9.15	2.98
Return on Equity (ROE)	-25.67%	-30.23%	-52.59%	-30.59%	-46.82%	-153.03%
Return on Assets (ROA)	-28.23%	-32.37%	-51.41%	-31.97%	-37.08%	-75.92%
Return on Invested Capital (ROIC)	-1787.17%	-2560.66%	-2627.80%	-708.54%	-427.49%	-859.68%
Return on Capital Employed (ROCE)	-29.63%	-34.73%	-56.01%	-35.12%	-44.19%	-96.47%
Buyback Yield / Dilution	-33.10%	-32.14%	-2.97%	-53.44%	-182.56%	-26.48%
Total Shareholder Return	-33.10%	-32.14%	-2.97%	-53.44%	-182.56%	-26.48%

SEC Filings: 10-K · 10-Q